TY  - GEN
AU  - Arnulf,Bertrand
AU  - Pylypenko,Halyna
AU  - Grosicki,Sebastian
AU  - Karamanesht,Ievgenii
AU  - Leleu,Xavier
AU  - van de Velde,Helgi
AU  - Feng,Huaibao
AU  - Cakana,Andrew
AU  - Deraedt,William
AU  - Moreau,Philippe
TI  - Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma
SN  - 1592-8721
PY  - 2013///1210
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Boronic Acids
KW  - Bortezomib
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Injections, Intravenous
KW  - Injections, Subcutaneous
KW  - Male
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Neoplasm Recurrence, Local
KW  - Prognosis
KW  - Pyrazines
KW  - Remission Induction
KW  - Survival Rate
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2012.067793
ER  -